Tina Self serves as the global lead for the Biologics Manufacturing Capability Cluster, responsible for clinical through commercial manufacturing of Bayer’s biologics portfolio. She also serves as the Site Head for Bayer’s biotech campus in Berkeley, California. Prior to taking on this role in June 2024, she has advanced through positions of increasing responsibility in Quality, Biologics Manufacturing and Site Management. She is the proud leader of a fantastic team focused on manufacturing products that serve the global hemophilia community as well as producing the next generation of life-changing medicines. Tina has more than 25 years of experience with diverse product platforms including small molecule, autologous drug therapy, enzyme replacement, MABs and recombinant proteins in and has held leadership roles at Sanofi Genzyme and EMD Serono. Tina holds bachelor’s and master’s degrees from Georgia Southwestern State University and Johns Hopkins University and an MBA from Florida Atlantic University.
&nsbp;
powered by Borlabs Cookie